Clinical Trial Update: Age of Blood in Sickle Cell Transfusion [Phase 2, Phase 3]

View source ↗

Summary

Results from a Phase 2/Phase 3 trial evaluating the impact of the age of transfused red blood cells on outcomes in sickle cell disease have been posted; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Sickle Cell Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-11-19